December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

30.27 -1.44 (-4.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
News headline image
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider ↗
Both of these companies could soon set the standard in their fields. 
Via The Motley Fool
News headline image
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy. ↗
There's probably a big enough pie here for everyone to get a slice. 
Via The Motley Fool
News headline image
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing ↗
Sometimes the next big thing stocks to buy and hold are flying well under the radar. Here are three to consider. 
Via InvestorPlace
News headline image
3 Underappreciated Stocks with Triple-Digit Upside: May 2024 ↗
There are plenty of underappreciated stocks on the market. In fact, here are three you may want to consider buying and holding today. 
Via InvestorPlace
News headline image
Market Whales and Their Recent Bets on VKTX Options ↗
 
Via Benzinga
News headline image
Where Will Viking Therapeutics Be in 5 Years? ↗
Could Viking Therapeutics become a big player in the GLP-1 drug market? 
Via The Motley Fool
News headline image
Smart Money Is Betting Big In VKTX Options ↗
 
Via Benzinga
News headline image
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. 
Via InvestorPlace
News headline image
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today ↗
What would a $100 investment in Viking Therapeutics back in 2022 be worth today? Prepare to be surprised. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition ↗
Investors should take a close look at these biotech stocks as they position themselves to provide high returns. 
Via InvestorPlace
News headline image
2 Stocks That Could 10x by 2035 ↗
These stocks are very promising, but it's important to consider the downside, too. 
Via The Motley Fool
News headline image
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound ↗
Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention. 
Via InvestorPlace
News headline image
Is Viking Therapeutics Stock a Buy? ↗
The stock could have room to soar higher if VK2735 obtains approval from regulators. 
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Viking Therapeutics? ↗
 
Via Benzinga
News headline image
Is It Too Late to Buy Viking Therapeutics Stock? ↗
This rising star probably won't burn out soon. 
Via The Motley Fool
News headline image
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic ↗
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day." 
Via Benzinga
Topics ETFs
News headline image
3 Growth Stocks That Could Be Millionaire-Makers: May Edition ↗
Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year. 
Via InvestorPlace
News headline image
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024 ↗
Consider following the recommendations of analysts and buy these small but mighty companies whose stocks are rising. 
Via InvestorPlace
News headline image
3 Monster Stocks in the Making You Can Buy Right Now ↗
These stocks might not be small for too much longer. 
Via The Motley Fool
News headline image
Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next? ↗
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason. 
Via InvestorPlace
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
News headline image
Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000 ↗
Top small-cap stocks to buy Viking Therapeutics, Celsius and Hippo make waves in the weight loss, energy drink, and insurance tech sectors. 
Via InvestorPlace
News headline image
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 ↗
These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet. 
Via InvestorPlace
News headline image
How Viking Therapeutics Stock Could 30x ↗
This mid-cap biopharma may one day be a titan of the industry. 
Via The Motley Fool
News headline image
Is Viking Therapeutics the Best Biotech Stock for You? ↗
With good mid-stage results and plenty of cash, Viking could be a winner. 
Via The Motley Fool
News headline image
The 3 Best Russell 2000 Stocks to Buy in May 2024 ↗
If you are looking for investments that will deliver high returns, these are the best Russell 2000 stocks to buy for your portfolio. 
Via InvestorPlace
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.